Seer, Inc. - Class A Common Stock (NQ:SEER)

2.090 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 25, 2026 Add to My Watchlist

Price and Volume

Volume	5,614
Open	2.090
Bid (Size)	1.990 (2,100)
Ask (Size)	2.020 (1,700)
Prev. Close	2.090
Today's Range	2.090 - 2.090
52wk Range	1.620 - 2.410
Shares Outstanding	61,423,263
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Radoff-JEC Group Issues Open Letter to Seer Inc.’s Board of Directors Regarding the Immediate Need for Significant Change

February 23, 2026

From On Behalf of The Radoff-JEC Group

Via Business Wire

Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

February 19, 2026

Nathan Basisty, Sasha Singh, Bruce Wilcox, and Mozhgan Boroumand among scientific leaders presenting unique proteomics-enabled biological insights

From Seer, Inc.

Via GlobeNewswire

Performance

YTD	+14.8%	+14.8%
1 Month	+7.7%	+7.7%
3 Month	+7.2%	+7.2%
6 Month	+1.5%	+1.5%
1 Year	-7.1%	-7.1%

More News

Seer to Participate in the TD Cowen 46th Annual Health Care Conference

February 18, 2026

From Seer, Inc.

Via GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

February 05, 2026

From Seer, Inc.

Via GlobeNewswire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

December 01, 2025

From Seer, Inc.

Via GlobeNewswire

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

November 07, 2025

From Seer, Inc.

Via GlobeNewswire

SEER INC (NASDAQ:SEER) Reports Q3 2025 Results with Narrow Revenue Beat and Reduced Losses ↗

November 06, 2025

Via Chartmill

Seer Reports Third Quarter 2025 Financial Results

November 06, 2025

From Seer, Inc.

Via GlobeNewswire

Seer to Participate in Upcoming November Investor Conferences

October 29, 2025

From Seer, Inc.

Via GlobeNewswire

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

October 16, 2025

From Seer, Inc.

Via GlobeNewswire

RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

October 16, 2025

From RetinalGeniX Technologies, Inc.

Via GlobeNewswire

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

October 10, 2025

From Seer, Inc.

Via GlobeNewswire

Seer Appoints Isaac Ro to its Board of Directors

September 02, 2025

From Seer, Inc.

Via GlobeNewswire

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26, 2025

From Seer, Inc.

Via GlobeNewswire

Seer (SEER) Q2 Revenue Jumps 32% ↗

August 07, 2025

Via The Motley Fool

Seer (SEER) Q2 2025 Earnings Call Transcript ↗

August 06, 2025

Via The Motley Fool

Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

August 06, 2025

From Seer, Inc.

Via GlobeNewswire

Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 31, 2025

From Seer, Inc.

Via GlobeNewswire

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

July 22, 2025

From Seer, Inc.

Via GlobeNewswire

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

June 01, 2025

From Seer, Inc.

Via GlobeNewswire

Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency

May 29, 2025

From Seer, Inc.

Via GlobeNewswire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 14, 2025

Via Chartmill

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

May 13, 2025

From Seer, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Seer, Inc. - Class A Common Stock publicly traded?

Yes, Seer, Inc. - Class A Common Stock is publicly traded.

What exchange does Seer, Inc. - Class A Common Stock trade on?

Seer, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Seer, Inc. - Class A Common Stock?

The ticker symbol for Seer, Inc. - Class A Common Stock is SEER on the Nasdaq Stock Market

What is the current price of Seer, Inc. - Class A Common Stock?

The current price of Seer, Inc. - Class A Common Stock is 2.090

When was Seer, Inc. - Class A Common Stock last traded?

The last trade of Seer, Inc. - Class A Common Stock was at 02/25/26 04:00 PM ET

What is the market capitalization of Seer, Inc. - Class A Common Stock?

The market capitalization of Seer, Inc. - Class A Common Stock is 128.37M

How many shares of Seer, Inc. - Class A Common Stock are outstanding?

Seer, Inc. - Class A Common Stock has 128M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.